Elastomeric Infusion Pumps Market Size & Growth Analysis to 2030

The global elastomeric infusion pumps market size was valued at around USD 1.2 billion in 2023 and projected to grow at a significant CAGR of over 8% during the forecast period from 2024 to 2030. The primary driver of market expansion is the escalating prevalence of chronic diseases. For instance, as outlined in the International Diabetes Federation Diabetes Atlas Tenth edition from December 2021, the global number of adults diagnosed with diabetes reached approximately 537 million in 2021. Projections indicate a further increase to 643 million by 2030 and a substantial rise to 783 million by 2045. Furthermore, data from the World Health Organization (WHO) released in April 2021 underscores the impact of chronic diseases, estimating that these conditions are anticipated to be responsible for 41 million annual fatalities, constituting 71% of all global deaths.

The growth of the elastomeric infusion pumps market is driven by several key factors. With a rising prevalence of chronic diseases and an expanding aging population, the demand for continuous and controlled drug delivery has increased. Elastomeric infusion pumps offer a practical solution, providing a steady release of medications, particularly crucial for patients with long-term therapeutic needs. The trend towards home healthcare and ambulatory settings further propels the market, as these pumps offer a portable and user-friendly option for at-home treatment. Technological advancements, coupled with the preference for non-electronic systems, contribute to the appeal of elastomeric pumps. Additionally, their cost-effectiveness, patient comfort, and regulatory support further stimulate adoption, making elastomeric infusion pumps integral in various medical applications, from postoperative pain management to chronic disease treatments. As healthcare providers continue to seek reliable and efficient drug delivery methods, the elastomeric infusion pumps market is poised for sustained growth and innovation.

Market Snapshot:

To know more about the research study, request sample papers

Market Drivers:

• Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, necessitates long-term and continuous drug administration. Elastomeric infusion pumps offer a convenient and efficient solution for such patients.
• Growing Aging Population: The global aging population is expanding, leading to a higher prevalence of chronic conditions that require continuous medication. Elastomeric infusion pumps are particularly valuable for elderly patients who may have difficulty with self-administration or frequent dosing.
• Advantages of Controlled Drug Delivery: Elastomeric infusion pumps provide a controlled and steady release of medications, ensuring a more constant therapeutic effect. This is especially crucial for drugs with narrow therapeutic windows or those requiring precise dosing schedules.
• Home Healthcare Trend: The increasing trend toward home healthcare and ambulatory settings drives the demand for devices that facilitate easy and safe administration of medications outside traditional hospital settings. Elastomeric infusion pumps offer a portable and user-friendly option for at-home treatment.
• Technological Advancements: Ongoing advancements in elastomeric pump technology, including improvements in materials, design, and features, enhance the overall performance and usability of these devices. This encourages healthcare providers to adopt them for various therapeutic applications.
• Preference for Non-Electronic Systems: Elastomeric infusion pumps operate without electronic components, batteries, or power sources. This simplicity makes them cost-effective, reliable, and suitable for use in environments where electronic devices may be less practical or pose challenges.
• Increasing Surgical Procedures: The growth in the number of surgeries, both inpatient and outpatient, contributes to the demand for postoperative pain management and other therapeutic infusions. Elastomeric pumps offer a convenient and effective method for delivering medications in these settings.
• Patient Comfort and Compliance: Elastomeric pumps are designed to be lightweight and portable, promoting patient mobility and comfort. The simplicity of these pumps may enhance patient compliance with prescribed medication regimens.

Market Insights:

The global elastomeric infusion pumps market is bifurcated into product type, application, end-user, and geography. On the basis of application, the market is further segmented into pain management, chemotherapy, chelation therapy, others. Anticipated as the fastest-growing segment in the market during the forecast period from 2024 to 2030, the chemotherapy sector is poised for expansion due to several factors. These include the escalating incidences and prevalence of diverse cancer types, a notable preference for extended home healthcare, and an increasing adoption of elastomer infusion pumps in ambulatory chemotherapy and analgesic infusion centers. To illustrate, recent statistics from Breastcancer.org’s January 2022 update reveal that approximately 1 in 8 women in the United States (about 13%) will develop invasive breast cancer in their lifetime. Furthermore, the projection for 2022 indicates an estimated 287,850 new cases of invasive breast cancer in U.S. women, marking an increase from the 276,480 new cases recorded in 2020. This underscores the crucial role of elastomeric infusion pumps, particularly in the chemotherapy domain, as an integral component of modern cancer treatment and care.

Pain Management: Elastomeric infusion pumps play a crucial role in pain management by delivering controlled doses of analgesic medications to patients. This application is particularly important in postoperative care, chronic pain conditions, and palliative care settings, providing a convenient and effective method for administering pain-relieving drugs over an extended period.

Chemotherapy: In oncology, elastomeric infusion pumps are utilized for chemotherapy, ensuring a continuous and controlled release of anticancer drugs. This application is vital in the treatment of various cancers, allowing for more consistent therapeutic levels of medications and reducing the need for frequent hospital visits.

Chelation Therapy: Elastomeric pumps find application in chelation therapy, a medical procedure used to treat heavy metal poisoning. The pumps deliver chelating agents gradually over a specified period, helping to remove toxic metals from the body. This controlled delivery is essential for the safety and effectiveness of chelation treatments.

Others: The “Others” category encompasses a range of additional medical applications where elastomeric infusion pumps may be utilized. This could include antibiotic therapy, nutritional support, and various intravenous treatments where a steady and continuous infusion of medication is required.

The elastomeric infusion pumps market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

• 2020-22 – Historical Year
• 2023 – Base Year
• 2024-2030 – Forecast Period

Market Segmentation:

By Product Type:

• Continuous Rate Elastomeric Pump
• Variable Rate Elastomeric Pump

By Application:

• Pain Management
• Chemotherapy
• Chelation Therapy
• Others

By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Geographically, North America dominated the global elastomeric infusion pumps market in the benchmark year and estimated to grow at the same trend over the forecast period. Renowned for its advanced healthcare infrastructure, particularly in the United States and Canada, the region boasts modern medical facilities and a well-established distribution network for medical devices. This infrastructure facilitates efficient procurement, distribution, and utilization of elastomeric infusion pumps across various healthcare settings.

Additionally, North America exhibits a high prevalence of chronic diseases, driving the demand for innovative medical technologies like elastomeric infusion pumps, which are integral in the management of conditions such as cancer, diabetes, and cardiovascular disorders. The region’s penchant for technological innovation, coupled with a favorable regulatory environment and substantial healthcare spending, further solidifies its position as a dominant force in the adoption and utilization of advanced medical devices.

Furthermore, North America’s preference for home healthcare and patient-centric treatment models contributes significantly to the widespread use of elastomeric infusion pumps. The growing trend towards home-based care aligns with the portable and user-friendly nature of these pumps, allowing patients to receive continuous medication delivery in the comfort of their homes. Moreover, heightened awareness and education about advanced medical treatments among healthcare professionals and the general population in North America foster a culture of innovation and early adoption of cutting-edge medical devices.

Competitive Assessment:

Some of the prominent market players operating in the global elastomeric infusion pumps market are Ambu A/s, Avanos Medical Inc., Baxter International Inc., B. Braun Melsungen AG, and Werfenlife SA (LeVenton SAU). Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Recent Developments:

• In March 2022, the FDA initiated a recall of Baxter Healthcare’s SIGMA Spectrum Infusion Pump due to multiple instances of a safety alarm malfunction. Reports indicated that the pump’s alarm system was failing to activate during upstream occlusion events, prompting the recall to address potential safety concerns. This action aimed to ensure the reliability and effectiveness of the infusion pump in various medical settings.
• In May 2020, responding to the urgent need for infusion pumps, the U.S. FDA issued a comprehensive umbrella emergency use authorization (EUA) for infusion pumps and related accessories. The issuance of EUAs played a pivotal role in expediting the availability of infusion pumps, addressing critical healthcare demands during emergency situations. This regulatory measure aimed to facilitate timely access to essential medical devices, ensuring a more agile response to evolving healthcare needs.
• In November 2020, Ambu Inc. established a partnership with Intalere to provide pain care management solutions. Through this collaboration, Intalere members gained access to the Ambu® ACTionTM Block Pain Pump, enhancing the options available for pain management within the healthcare system.
• Additionally, in February 2020, LTC Medical engaged in a collaborative effort with Woo Young Medical, with the primary goal of expanding its distribution network in the Australian region. This strategic collaboration also opened avenues for the development of new technologies centered around elastomeric infusion, further advancing medical solutions in the infusion pump domain.

Key Companies:

• Ambu A/s
• Avanos Medical Inc.
• Baxter International Inc.
• Braun Melsungen AG
• Werfenlife SA (LeVenton SAU)
• Nipro Corporation
• Woo Young Medical Co.
• Epic Medical Pte Ltd.
• Daiken Medical Co. Ltd.
• Smiths Medical Inc. (Smiths Group)
• Fresenius Kabi AG

Key Questions Answered by Elastomeric Infusion Pumps Market Report

• Global elastomeric infusion pumps market forecasts from 2024-2030
• Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
• Elastomeric infusion pumps submarket forecasts from 2024-2030 covering the market by product type, application, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level elastomeric infusion pumps markets from 2024-2030
• Competitive Landscape and market positioning of top 10 players operating in the market